Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

Dian Wang, Qiang Zhang, Charles D. Blanke, George D. Demetri, Michael C. Heinrich, James C. Watson, John P. Hoffman, Scott Okuno, John M. Kane, Margaret Von Mehren, Burton L. Eisenberg

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalAnnals of surgical oncology
Volume19
Issue number7
DOIs
StatePublished - Jul 1 2012

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this